G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $130,176 | -53.2% | 90,400 | -12.9% | 0.00% | -100.0% |
Q1 2023 | $278,138 | -87.3% | 103,783 | -74.3% | 0.00% | -85.7% |
Q4 2022 | $2,189,935 | -33.1% | 403,303 | +53.8% | 0.01% | -36.4% |
Q3 2022 | $3,275,000 | +492.2% | 262,182 | +134.2% | 0.01% | +450.0% |
Q2 2022 | $553,000 | +203.8% | 111,932 | +368.6% | 0.00% | +100.0% |
Q1 2022 | $182,000 | -86.9% | 23,885 | -82.5% | 0.00% | -66.7% |
Q4 2021 | $1,391,000 | +22.3% | 136,235 | +60.8% | 0.00% | 0.0% |
Q3 2021 | $1,137,000 | -91.7% | 84,731 | -86.5% | 0.00% | -90.3% |
Q2 2021 | $13,729,000 | -31.8% | 625,754 | -25.3% | 0.03% | -40.4% |
Q1 2021 | $20,145,000 | +296.4% | 837,276 | +196.4% | 0.05% | +246.7% |
Q4 2020 | $5,082,000 | +169.5% | 282,475 | +73.0% | 0.02% | +114.3% |
Q3 2020 | $1,886,000 | +41.4% | 163,310 | +34.9% | 0.01% | -36.4% |
Q1 2020 | $1,334,000 | -24.5% | 121,049 | +81.0% | 0.01% | +120.0% |
Q4 2019 | $1,767,000 | +582.2% | 66,871 | +487.6% | 0.01% | +400.0% |
Q3 2019 | $259,000 | -87.9% | 11,380 | -91.2% | 0.00% | -85.7% |
Q1 2019 | $2,148,000 | +47.8% | 129,420 | +70.6% | 0.01% | +16.7% |
Q4 2018 | $1,453,000 | -7.3% | 75,857 | +79.3% | 0.01% | +20.0% |
Q1 2018 | $1,567,000 | +217.8% | 42,305 | +70.1% | 0.01% | +150.0% |
Q4 2017 | $493,000 | – | 24,873 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |